Close Menu

NEW YORK (GenomeWeb) – OpGen announced today that it has partnered with Beth Israel Deaconess Medical Center (BIDMC) on a verification study for OpGen's Acuitas AMR Gene Panel u5.47 Assay and the Acuitas Lighthouse Knowledgebase. The study will be among the first to examine potential diagnostic and antibiotic decision-making improvements that may be possible using rapid molecular testing and bioinformatics.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.